Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Ruxolitinib formulation for reduction of itch in atopic dermatitis

Ruxolitinib formulation for reduction of itch in atopic dermatitis

US Patent 11510923 · Granted Nov 29, 2022

Estimated economic value: $54,386,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Biomarkers for vitiligo2025
Ruxolitinib formulation for reduction of itch in atopic dermatitis2025
Ruxolitinib formulation for reduction of itch in atopic dermatitis2025
Ruxolitinib formulation for reduction of itch in atopic dermatitis2025
Ruxolitinib formulation for reduction of itch in atopic dermatitis2025
Ruxolitinib formulation for reduction of itch in atopic dermatitis2025
Biomarkers for graft-versus-host disease2025
Treatment of hidradenitis suppurativa using JAK inhibitors2025
Topical treatment of vitiligo by a JAK inhibitor2025
Topical treatment of vitiligo by a JAK inhibitor2025
Topical treatment of vitiligo by a JAK inhibitor2025
Biomarkers for graft-versus-host disease2025